← All Papers

"CAR-T Therapy for Myasthenia Gravis: Deep Research Analysis"

AURIV Healthcare AI — 2026-02-19

Comprehensive analysis of chimeric antigen receptor T-cell therapy for autoimmune myasthenia gravis. All claims verified against peer-reviewed sources via Reality Engine.

Premium Research

This paper requires a Pro subscription ($29/mo). View plans.